Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
02/2002
02/13/2002EP1178797A1 Inhibitors of impdh enzyme
02/13/2002EP1049695B1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
02/13/2002EP0833831B1 Process for preparing n-phosphonomethyliminodiacetic acid
02/13/2002EP0699069B1 Endothelin receptor antagonists
02/13/2002CN1335849A Pyrrolopyrimidines as protein kinase inhibitors
02/13/2002CN1335320A Synthesis of diisooctyl molybdenum dithiophosphate
02/12/2002US6346648 Polycarboxy alcohol amine as amphoteric suractants for shampoo and hair conditioners
02/12/2002US6346640 Method for producing cyanovaleric acid or esters thereof
02/12/2002US6346615 Spiroadamantyl dioxetanes bearing an alkoxy substituent, and an aromatic substituent on the dioxetane ring can be activated to chemiluminesce if the aromatic substituent bears a moiety that is cleaved by an enzyme
02/12/2002US6346521 Osteogenesis promoters for bone disorders
02/12/2002US6346324 Cis-bridged metal complexes and catalyst systems containing the same
02/12/2002US6346276 Composition containing useful substances originating in fishes and shellfishes and process for the preparation of the substances
02/12/2002CA2241679C Phosphonic acid diester derivatives
02/12/2002CA2110273C Benzimidazole derivatives, their preparation process and their use in the fields of therapeutics and cosmetics
02/12/2002CA2046755C /2r/-2-[di/2-propyl/phosphonylmethoxy]-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane, its preparation and use
02/07/2002WO2002011190A2 Precursors for incorporating nitrogen into a dielectric layer
02/07/2002WO2002010431A2 Functional biopolymer modification reagents and uses thereof
02/07/2002WO2002010178A1 Adamantyl groups containing phosphane ligands, the production and use thereof in catalytical reactions
02/07/2002WO2002010177A1 Ammonium salts of inositol hexaphosphate and uses thereof
02/07/2002WO2002010114A2 Transesterified fatty esters for lubricant and refrigerant oil system
02/07/2002WO2002009752A2 Immunological adjuvant compounds
02/07/2002WO2002009723A2 Ammonium salts of hemoglobin allosteric effectors, and uses thereof
02/07/2002WO2002009686A2 Cdc25 phosphatase inhibitors
02/07/2002WO2002009647A2 Biological component comprising artificial membrane
02/07/2002WO2001079213A3 Polymer-supported synthesis of heteroatom bidentate ligands for catalysis
02/07/2002WO2001030333A3 Tissue factor antagonists and methods of use thereof
02/07/2002US20020016513 Use of molecular weight-enlarged catalysts in a process for asymmetric, continous hydrogenation, novel molecular weight-enlarged ligands and catalysts
02/07/2002US20020016504 Reacting iminophosphoranes with phosphorus oxytrichloride in aprotic solvent, wherein by-product aminophosphonium chlorides are removed via solid-liquid separation, then water washing remaining solution
02/07/2002US20020016503 By-product inhibition
02/07/2002US20020016497 Purified sulfonated organophosphorus compounds and catalysis of organic reactions therewith
02/07/2002US20020016484 Bidentate ligand, catalyst system containing such ligand and a process for the carbonylation of ethylenically or acetylenically unsaturated compounds using such a catalyst system
02/07/2002US20020016472 Protecting groups with increased photosensitivities
02/07/2002US20020016384 Hydrolysis-stable and polymerizable acrylophosphonic acid
02/07/2002US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use
02/07/2002US20020016311 Nitrate esters and their use for neurological conditions
02/07/2002US20020016255 Magnesium-zirconium alkoxide complexes and polymerization catalysts made therefrom
02/07/2002US20020016010 Synthesis of compounds and libraries of compounds
02/07/2002US20020016003 Chemoselective ligation
02/07/2002US20020015884 Ionic liquids II
02/07/2002US20020015826 Zwitterionic iodonium compounds and methods of application
02/07/2002US20020015682 An ethylenically unsaturated monophosphate such as pentaerythritol trimethyl ether monophosphate acid ether; etching a tooth surface; sequentially applying the above compound and a 2-hydroxyethyl methacrylate in multiple layers
02/07/2002DE10037961A1 Neue Phosphanliganden, deren Herstellung und ihre Verwendung in katalytischen Reaktionen New phosphine ligands, their preparation and their use in catalytic reactions
02/07/2002CA2417262A1 Cdc25 phosphatase inhibitors
02/07/2002CA2319694A1 Compound
02/06/2002EP1178050A2 Fluoroalkylphosphates for use in electrochemical cells
02/06/2002EP1177310A1 Method for producing l-phosphinothricine by enzymatic transamination with aspartate
02/06/2002EP1177240A1 Process for the preparation of copolymers of carbon monoxide and olefinically unsaturated compounds
02/06/2002EP1177200A1 Ligands for metabotropic glutamate receptors
02/06/2002EP1177199A1 Ionic liquids and production and use thereof
02/06/2002EP1176952A2 2r,4s-hydroxyitraconazole isomers
02/06/2002EP1176937A1 Self-adhesive polymerizable monomer and dental/medical compositions therefrom
02/06/2002EP0977732B1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups on a di- oligo- or polyene base
02/06/2002EP0888364B1 Process to prepare a multidentate phosphite compound
02/06/2002EP0845991B1 Use of phenol substituted diphosphonates as antineoplastic agents
02/06/2002CN1334810A Process for preparing tricyclic compound having antihistaminic activity
02/06/2002CN1334796A Method for producing or purifying onium hydroxides by means of electrodialysis
02/06/2002CN1078877C Improved metal-ligand complex catalyzed processes
02/05/2002US6344576 Phospholipid-analogous compounds
02/05/2002US6344567 Process for producing ascorbic acid-2-phosphoric ester salts
02/05/2002US6344459 Treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis
02/05/2002US6344079 Alkane and polyamine solvent compositions for liquid delivery chemical vapor deposition
02/04/2002CA2354794A1 Fluoroalkyl phosphates for use in electrochemical cells
01/2002
01/31/2002WO2002008241A2 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
01/31/2002WO2002008236A1 Ligands, complex compounds and their use for polymerising olefins
01/31/2002WO2002008235A1 Medicament for oral application, containing aminopropyl phosphonic acid esters as an active ingredient
01/31/2002WO2002008233A2 Novel phosphorus-containing monomers and flame retardant high impact monovinylidene aromatic polymer compositions derived therefrom
01/31/2002WO2002008213A1 Colchinol derivatives as angiogenesis inhibitors
01/31/2002WO2002008211A2 Benzothiazepines and their use as antihyperlipidemics
01/31/2002WO2002008205A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity
01/31/2002WO2002008189A1 Compounds and inhibitors of phospholipases
01/31/2002WO2002008169A1 Ruthenium complexes and their use in asymmetric hydrogenation
01/31/2002WO2002008164A1 Secondary c10-18 surfactant alcohols
01/31/2002WO2002007669A2 Phospholipid derivatives of valproic acid and mixtures thereof
01/31/2002WO2001068250A3 Separation of reaction products containing organophosphorus complexes
01/31/2002WO2001064698A3 Macrocyclic ligands and complexes thereof
01/31/2002WO2001060416A3 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
01/31/2002US20020013503 Catalytic hydroformylation
01/31/2002US20020013488 Reacting phosphorus oxychloride and hydroxyaromatic compound
01/31/2002US20020013476 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
01/31/2002US20020013381 Ionic compounds with delocalized anionic charge, and their use as ion conducting components or as catalysts
01/31/2002US20020013374 Administering compound effective to inhibit binding of an amyloid beta peptide with alpha-7 nicotinic acetylcholine receptors
01/31/2002US20020013293 Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
01/31/2002US20020013287 Nucleosides, nucleoside analogs, abasic nucleosides, or heterocyclic derivatives linked by a phophodiester, a phosphorothioate or phosphonate group; sustained release; anticarcinogenic agents, viricides and microbiocides
01/31/2002US20020012631 As imaging agents for the diagnosis of cardiovascular disorders such as thromboembolic disease or atherosclerosis, infectious disease and cancer
01/31/2002DE19881732C1 New phosphodiesterase inhibiting 2-phenyl-imidazotriazinone derivatives useful for treating e.g. cardiovascular, cerebrovascular and/or urogenital diseases
01/31/2002DE10035700A1 Komplexverbindungen und ihre Verwendung zur Polymerisation von Olefinen Complex compounds and their use for the polymerization of olefins
01/31/2002DE10035654A1 Liganden, Komplexverbindungen und ihre Verwendung zur Polymerisation von Olefinen Ligand complex compounds and their use for the polymerization of olefins
01/31/2002DE10035617A1 Sekundäre C¶1¶¶0¶-C¶1¶¶8¶-Tensidalkohole Secondary C¶1¶¶0¶-C¶1¶¶8¶-surfactant alcohols
01/31/2002CA2725819A1 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
01/31/2002CA2417127A1 Compounds and inhibitors of phospholipases
01/31/2002CA2415738A1 Ruthenium complexes and their use in asymmetric hydrogenation
01/31/2002CA2415715A1 Secondary c10-c18 surfactant alcohols
01/31/2002CA2410562A1 Colchinol derivatives as angiogenesis inhibitors
01/30/2002EP1175447A1 Polymerisable surfactants
01/30/2002EP1175426A1 Bidentate organophosphorous ligands and their use
01/30/2002EP1175425A2 Inhibitors of intestinal apical membrane na/phosphate co-transportation
01/30/2002EP1175423A1 Weakly coordinating anions containing polyfluoroalkoxide ligands
01/30/2002EP1175382A1 Method for the dihydroxylation of olefins using transition-metal catalysts
01/30/2002EP1045897B1 Enzyme catalyzed therapeutic agents
01/30/2002EP0689611B1 Improved enhancement of chemiluminescent assays